In this edition, CDC issues a health advisory concerning flesh-eating bacterium, staging for melanoma does not represent accurate recurrence and mortality and more.
Read the full coverage here:
CDC issues health advisory about recent reports of fatal Vibrio vulnificus
Study finds melanoma treatment costs have increased, but so has survival
Melanoma staging system inaccurately reflects recurrence, mortality risk
Study: Nemolizumab shows promise as prurigo nodularis treatment
Adverse events after ICI treatment linked to improved outcomes in patients with melanoma
References:
Bateni SB, et al. JAMA Dermatol. 2023;doi:10.1001/jamadermatol.2023.3179.
Deng J, et al. JAMA Dermatol. 2023;doi:10.1001/jamadermatol.2023.2609.
Du Y, et al. JAMA Dermatol. 2023;doi:10.1001/jamadermatol.2023.3003.
Helvind NM, et al. JAMA Dermatol. 2023;doi:10.1001/jamadermatol.2023.3256.
